1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow CCTU: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients Experimental drug: Aprepitant, Experimental drug: Ondansetron, Experimental drug: Dexamethasone - Breast Cancer | Phase 3 | Completed | CCTU | 120 | 2017-03-23 | 2021-07-28 |
Breast Neoplasms (1)
Hong Kong (1)